14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days £141.16 £183.01 Thursday, 8th Feb 2024 ERGO.L stock ended at £1,346.00. During the day the stock fluctuated 0% from a day low at £1,346.00 to a day high of £1,346.00.
90 days £141.16 £227.30
52 weeks £84.73 £227.30

Historical Entia Biosciences Inc prices

Date Open High Low Close Volume
Nov 10, 2023 £1,348.00 £1,348.00 £1,346.00 £1,346.00 281 435
Nov 09, 2023 £1,346.00 £1,348.00 £1,344.04 £1,346.00 7 632 217
Nov 08, 2023 £1,348.00 £1,348.00 £1,344.00 £1,344.00 1 128 834
Nov 07, 2023 £1,344.00 £1,346.00 £1,344.00 £1,344.00 47 606
Nov 06, 2023 £1,346.00 £1,348.38 £1,344.00 £1,344.00 16 436
Nov 03, 2023 £1,344.00 £1,346.00 £1,342.00 £1,346.00 363 073
Nov 02, 2023 £1,344.00 £1,344.00 £1,342.00 £1,344.00 68 427
Nov 01, 2023 £1,344.00 £1,344.00 £1,342.00 £1,344.00 235 110
Oct 31, 2023 £1,344.00 £1,344.00 £1,342.00 £1,342.00 64 122
Oct 30, 2023 £1,342.00 £1,344.00 £1,342.00 £1,342.00 1 236 949
Oct 27, 2023 £1,344.00 £1,344.00 £1,342.00 £1,342.00 207 171
Oct 26, 2023 £1,342.00 £1,344.00 £1,340.00 £1,340.00 116 292
Oct 25, 2023 £1,344.00 £1,344.00 £1,340.00 £1,340.00 1 928 699
Oct 24, 2023 £1,342.00 £1,342.00 £1,340.00 £1,342.00 3 063 708
Oct 23, 2023 £1,342.00 £1,342.43 £1,340.00 £1,342.00 3 730 431
Oct 20, 2023 £1,326.00 £1,330.00 £1,326.00 £1,328.00 816 372
Oct 19, 2023 £1,330.00 £1,331.22 £1,324.32 £1,326.00 38 045
Oct 18, 2023 £1,340.00 £1,340.00 £1,325.00 £1,330.00 7 271 968
Oct 17, 2023 £1,340.00 £1,340.00 £1,330.00 £1,334.00 549 685
Oct 16, 2023 £1,348.00 £1,348.00 £1,330.00 £1,332.00 240 510
Oct 13, 2023 £1,336.00 £1,342.00 £1,332.00 £1,334.00 271 276
Oct 12, 2023 £1,336.00 £1,346.00 £1,336.00 £1,340.00 433 054
Oct 11, 2023 £1,350.00 £1,350.00 £1,338.00 £1,342.00 106 305
Oct 10, 2023 £1,338.00 £1,342.00 £1,338.00 £1,342.00 450 425
Oct 09, 2023 £1,342.00 £1,342.00 £1,334.00 £1,338.00 137 934
Click to get the best stock tips daily for free!

About Entia Biosciences Inc

Entia Biosciences Ergomed plc, together with its subsidiaries, provides clinical trial planning, management, and monitoring; and drug safety and medical information services in the United Kingdom, rest of Europe, the Middle East, Africa, North America, Asia, and Australia. It operates through two segments, Clinical Research Services and Pharmacovigilance. The company provides and manages clinical development, post-approval management, and pharmacovigilance service... ERGO.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT